Prothena | Betriebsaufwand





Betriebsaufwand Veränderung Datum
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
Akebia Therapeutics USD 43.82M 16.98M 2025-03
ALKERMES USD 1.73B 1.44B 2025-09
Alnylam Pharmaceuticals USD 881.04M 91.16M 2025-09
Amgen USD 5.9B 773M 2025-12
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Exelixis USD 362.75M 21.35M 2025-12
Immunic USD 25.73M 2.91M 2024-09
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
MacroGenics USD 67M 8M 2025-09
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Prothena USD 42.18M 14.25M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Ultragenyx Pharmaceutical USD 330.82M 56.44M 2025-09
Vertex Pharmaceuticals USD 1.84B 27.1M 2025-09
Xoma USD 22.84M 1.67M 2024-09


Prothena Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.